# Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain

> **NCT03005899** · PHASE3 · TERMINATED · sponsor: **SymBio Pharmaceuticals** · enrollment: 49 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** SyB P-1501
- **DRUG:** SyB P-1501 placebo

## Key facts

- **NCT ID:** NCT03005899
- **Lead sponsor:** SymBio Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-21
- **Primary completion:** 2017-07-21
- **Final completion:** 2017-07-21
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Clinical trial was terminated due to discontinuation of drug product by the investigational drug supplier.
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03005899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03005899, "Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03005899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*